Company Filing History:
Years Active: 2007
Title: Innovations of Alexandra Maria Pietersen
Introduction
Alexandra Maria Pietersen is a notable inventor based in Leiden, Netherlands. She has made significant contributions to the field of gene therapy, particularly in the development of gene delivery vehicles that target tumor cells. Her work focuses on utilizing viral proteins to induce apoptosis in cancer cells while sparing normal cells.
Latest Patents
Pietersen holds a patent for a gene delivery vehicle expressing the apoptosis-inducing proteins VP2 and/or apoptin. This invention relates to gene delivery vehicles that comprise nucleic acid molecules encoding these proteins, which are derived from the Chicken Anaemia Virus. The technology aims to enhance anti-tumor therapies by selectively inducing apoptosis in various human tumor cells while minimizing effects on normal, non-malignant cells. Additionally, her invention has implications for the diagnosis of cancer and related conditions such as hyperplasia, metaplasia, and dysplasia.
Career Highlights
Alexandra Pietersen is associated with Leadd B.V., where she continues to advance her research in gene therapy. Her innovative approach to cancer treatment has positioned her as a key figure in the field. With a focus on developing effective therapies, she is dedicated to improving patient outcomes through her inventions.
Collaborations
Pietersen collaborates with Matheus Hubertus Maria Noteborn, contributing to the advancement of their shared research goals. Their partnership enhances the potential for breakthroughs in gene therapy and cancer treatment.
Conclusion
Alexandra Maria Pietersen's work exemplifies the intersection of innovation and healthcare. Her contributions to gene delivery systems represent a promising avenue for cancer therapies, showcasing the potential of targeted treatments in modern medicine.